• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PAK4-LIMK1信号通路在HGF下游驱动前列腺癌细胞迁移。

A PAK4-LIMK1 pathway drives prostate cancer cell migration downstream of HGF.

作者信息

Ahmed Tasneem, Shea Kerry, Masters John R W, Jones Gareth E, Wells Claire M

机构信息

Randall Division of Cell and Molecular Biophysics, King's College London, UK.

出版信息

Cell Signal. 2008 Jul;20(7):1320-8. doi: 10.1016/j.cellsig.2008.02.021. Epub 2008 Mar 12.

DOI:10.1016/j.cellsig.2008.02.021
PMID:18424072
Abstract

Hepatocyte growth factor (HGF) is associated with tumour progression and increases the invasiveness of prostate carcinoma cells. Cell migration and invasion requires reorganisation of the actin cytoskeleton; processes mediated by the Rho family GTPases. p21 activated kinase 4 (PAK4), an effector of the Rho family protein Cdc42, is activated downstream of HGF. We report here the novel finding that in prostate cancer cells PAK4 binds to and phosphorylates LIM kinase 1 (LIMK1) in an HGF-dependent manner. We show for the first time that variations in the level of PAK4 expression change the level of cofilin phosphorylation in cells, a change we correlate with LIMK1 activity, cell morphology and migratory behaviour. We identify for the first time a direct and localised interaction between PAK4 and LIMK1 within cells using FRET: FLIM. Moreover we show here that HGF mediates this interaction which is concentrated in small foci at the cell periphery. PAK4 and LIMK1 act synergistically to increase cell migration speed, whilst a reduction in PAK4 expression decreases cell speed. It is well established that unphosphorylated (active) cofilin is a required to drive cell migration. Our results support a model whereby HGF-stimulated cell migration also requires a cofilin phosphorylation step that is mediated by PAK4.

摘要

肝细胞生长因子(HGF)与肿瘤进展相关,并增加前列腺癌细胞的侵袭性。细胞迁移和侵袭需要肌动蛋白细胞骨架的重组,这一过程由Rho家族GTP酶介导。p21活化激酶4(PAK4)是Rho家族蛋白Cdc42的效应器,在HGF下游被激活。我们在此报告一项新发现,即在前列腺癌细胞中,PAK4以HGF依赖的方式与LIM激酶1(LIMK1)结合并使其磷酸化。我们首次表明,PAK4表达水平的变化会改变细胞中丝切蛋白的磷酸化水平,这种变化与LIMK1活性、细胞形态和迁移行为相关。我们首次使用荧光共振能量转移:荧光寿命成像(FRET: FLIM)在细胞内鉴定出PAK4与LIMK1之间直接且局部的相互作用。此外,我们在此表明HGF介导这种相互作用,其集中在细胞周边的小焦点处。PAK4和LIMK1协同作用以提高细胞迁移速度,而PAK4表达的降低会降低细胞速度。众所周知,未磷酸化(活性)的丝切蛋白是驱动细胞迁移所必需的。我们的结果支持一种模型,即HGF刺激的细胞迁移也需要由PAK4介导的丝切蛋白磷酸化步骤。

相似文献

1
A PAK4-LIMK1 pathway drives prostate cancer cell migration downstream of HGF.PAK4-LIMK1信号通路在HGF下游驱动前列腺癌细胞迁移。
Cell Signal. 2008 Jul;20(7):1320-8. doi: 10.1016/j.cellsig.2008.02.021. Epub 2008 Mar 12.
2
PAK4 kinase activity and somatic mutation promote carcinoma cell motility and influence inhibitor sensitivity.PAK4 激酶活性和体细胞突变促进癌细胞迁移,并影响抑制剂敏感性。
Oncogene. 2013 Apr 18;32(16):2114-20. doi: 10.1038/onc.2012.233. Epub 2012 Jun 11.
3
PAK4: a pluripotent kinase that regulates prostate cancer cell adhesion.PAK4:一种多能激酶,可调节前列腺癌细胞黏附。
J Cell Sci. 2010 May 15;123(Pt 10):1663-73. doi: 10.1242/jcs.055707. Epub 2010 Apr 20.
4
Effects of PAK4/LIMK1/Cofilin-1 signaling pathway on proliferation, invasion, and migration of human osteosarcoma cells.PAK4/LIMK1/Cofilin-1 信号通路对人骨肉瘤细胞增殖、侵袭和迁移的影响。
J Clin Lab Anal. 2020 Sep;34(9):e23362. doi: 10.1002/jcla.23362. Epub 2020 May 28.
5
Pak4, a novel Gab1 binding partner, modulates cell migration and invasion by the Met receptor.Pak4是一种新型的Gab1结合蛋白,通过Met受体调节细胞迁移和侵袭。
Mol Cell Biol. 2009 Jun;29(11):3018-32. doi: 10.1128/MCB.01286-08. Epub 2009 Mar 16.
6
DGCR6L, a novel PAK4 interaction protein, regulates PAK4-mediated migration of human gastric cancer cell via LIMK1.DGCR6L,一种新型 PAK4 相互作用蛋白,通过 LIMK1 调节人胃癌细胞中 PAK4 介导的迁移。
Int J Biochem Cell Biol. 2010 Jan;42(1):70-9. doi: 10.1016/j.biocel.2009.09.008. Epub 2009 Sep 22.
7
Overexpression of P21-activated kinase 4 is associated with poor prognosis in non-small cell lung cancer and promotes migration and invasion.P21激活激酶4的过表达与非小细胞肺癌的不良预后相关,并促进迁移和侵袭。
J Exp Clin Cancer Res. 2015 May 15;34(1):48. doi: 10.1186/s13046-015-0165-2.
8
LCH-7749944, a novel and potent p21-activated kinase 4 inhibitor, suppresses proliferation and invasion in human gastric cancer cells.LCH-7749944,一种新型强效的 p21 激活激酶 4 抑制剂,可抑制人胃癌细胞的增殖和侵袭。
Cancer Lett. 2012 Apr 1;317(1):24-32. doi: 10.1016/j.canlet.2011.11.007. Epub 2011 Nov 13.
9
Cytoskeletal changes regulated by the PAK4 serine/threonine kinase are mediated by LIM kinase 1 and cofilin.由PAK4丝氨酸/苏氨酸激酶调节的细胞骨架变化由LIM激酶1和丝切蛋白介导。
J Biol Chem. 2001 Aug 24;276(34):32115-21. doi: 10.1074/jbc.M100871200. Epub 2001 Jun 18.
10
Combined LIM kinase 1 and p21-Activated kinase 4 inhibitor treatment exhibits potent preclinical antitumor efficacy in breast cancer.联合 LIM 激酶 1 和 p21 激活激酶 4 抑制剂治疗在乳腺癌中表现出强大的临床前抗肿瘤疗效。
Cancer Lett. 2020 Nov 28;493:120-127. doi: 10.1016/j.canlet.2020.08.006. Epub 2020 Aug 21.

引用本文的文献

1
Regulation and signaling of the LIM domain kinases.LIM 结构域激酶的调控与信号传导。
Bioessays. 2025 Jan;47(1):e2400184. doi: 10.1002/bies.202400184. Epub 2024 Oct 3.
2
Role of actin-binding proteins in prostate cancer.肌动蛋白结合蛋白在前列腺癌中的作用。
Front Cell Dev Biol. 2024 Jul 11;12:1430386. doi: 10.3389/fcell.2024.1430386. eCollection 2024.
3
PAK4 inhibition augments anti-tumour effect by immunomodulation in oral squamous cell carcinoma.PAK4 抑制通过免疫调节增强口腔鳞状细胞癌的抗肿瘤作用。
Sci Rep. 2024 Jun 18;14(1):14092. doi: 10.1038/s41598-024-64126-0.
4
LIM Kinases, LIMK1 and LIMK2, Are Crucial Node Actors of the Cell Fate: Molecular to Pathological Features.LIM 激酶,LIMK1 和 LIMK2,是细胞命运的关键节点作用因子:从分子到病理特征。
Cells. 2023 Mar 4;12(5):805. doi: 10.3390/cells12050805.
5
Cofilin Acts as a Booster for Progression of Malignant Tumors Represented by Glioma.丝切蛋白作为以胶质瘤为代表的恶性肿瘤进展的促进因子。
Cancer Manag Res. 2022 Nov 24;14:3245-3269. doi: 10.2147/CMAR.S389825. eCollection 2022.
6
Inka2, a novel Pak4 inhibitor, regulates actin dynamics in neuronal development.Inka2,一种新型的 Pak4 抑制剂,调节神经元发育中的肌动蛋白动态。
PLoS Genet. 2022 Oct 27;18(10):e1010438. doi: 10.1371/journal.pgen.1010438. eCollection 2022 Oct.
7
The microtubule cytoskeleton: An old validated target for novel therapeutic drugs.微管细胞骨架:新型治疗药物的一个古老且经证实的靶点。
Front Pharmacol. 2022 Sep 15;13:969183. doi: 10.3389/fphar.2022.969183. eCollection 2022.
8
Differences in Prostate Cancer Transcriptomes by Age at Diagnosis: Are Primary Tumors from Older Men Inherently Different?前列腺癌转录组学的年龄差异:老年男性的原发肿瘤是否存在固有差异?
Cancer Prev Res (Phila). 2022 Dec 1;15(12):815-825. doi: 10.1158/1940-6207.CAPR-22-0212.
9
Differential roles and regulation of the protein kinases PAK4, PAK5 and PAK6 in melanoma cells.蛋白激酶 PAK4、PAK5 和 PAK6 在黑色素瘤细胞中的差异作用和调控。
Biochem J. 2022 Aug 31;479(16):1709-1725. doi: 10.1042/BCJ20220184.
10
The significance of PAK4 in signaling and clinicopathology: A review.PAK4在信号传导和临床病理学中的意义:综述
Open Life Sci. 2022 Jun 20;17(1):586-598. doi: 10.1515/biol-2022-0064. eCollection 2022.